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Due to atrophy, muscle weakness is a common occurrence in rheumatoid arthritis (RA). The majority of human studies are
conducted on the vastus lateralis muscle—a muscle with mixed ﬁber type—but little comparative data between multiple muscles
in either rodent or human models are available. The current study therefore assessed both muscle ultrastructure and selected
redox indicators across various muscles in a model of collagen-induced rheumatoid arthritis in female Sprague-Dawley rats.
Only three muscles, the gastrocnemius, extensor digitorum longus (EDL), and soleus, had lower muscle mass (38%, 27%, and 25%
loss of muscle mass, respectively; all at least P < 0 01), while the vastus lateralis muscle mass was increased by 35% (P < 0 01) in
RA animals when compared to non-RA controls. However, all four muscles exhibited signs of deterioration indicative of
rheumatoid cachexia. Cross-sectional area was similarly reduced in gastrocnemius, EDL, and soleus (60%, 58%, and 64%,
respectively; all P < 0 001), but vastus lateralis (22% smaller, P < 0 05) was less aﬀected, while collagen deposition was
signiﬁcantly increased in muscles. This pathology was associated with signiﬁcant increases in tissue levels of reactive oxygen
species (ROS) in all muscles except the vastus lateralis, while only the gastrocnemius had signiﬁcantly increased levels of lipid
peroxidation (TBARS) and antioxidant activity (FRAP). Current data illustrates the diﬀerential responses of diﬀerent skeletal
muscles of the hindlimb to a chronic inﬂammatory challenge both in terms of redox changes and resistance to cachexia.
1. Introduction
There can be no doubt that individuals suﬀering from rheu-
matoid arthritis (RA) have signiﬁcantly decreased quality of
life. In addition to the chronic pain and other primary symp-
toms arising from the inﬂammatory processes in joints, the
majority of patients also report skeletal muscle weakness
[1]. However, there is a disconnection between the degree
of rheumatoid cachexia (deﬁned as arthritis-associated loss
of muscle mass with little or no loss of fat mass [2]) and the
relatively more severe degree of muscle weakness experi-
enced. Initially, the more severe loss of strength was ascribed
to joint deformation and pain [3], but more recently,
contractile dysfunction, mediated by tumor necrosis factor
(TNF), was implicated, with TNF reported to decrease ?spe-
ciﬁc force by increasing cytosolic oxidant activity in the
muscle [4].
The pathology of skeletal muscle in patients with RA is
clearly complex and much research has already been
conducted in this context, so that at least a partial picture
of role players is available. For example, while neuromuscular
fatigue (assessed by electromyography) was reported to
weakly correlate with subjective perception of fatigue and
physical activity level, it did not correlate to either clinical
proﬁle or treatment features [5]. This suggests that while
advancement of emotional well-being should form part of
treatment strategy, neuromuscular pathology is probably
not a major role player in RA. In contrast, increased muscle
inﬂammatory cytokine levels, altered expression of genes
involved in muscle repair and glycolytic metabolism, as well
as increased levels of ﬁbrosis-associated amino acids, corre-
lated with disease progression, physical inactivity, and pain
in a large cohort of RA patients [6]. These data, generated
from the vastus lateralis muscle, and speciﬁcally the ﬁnding
related to altered glycolytic metabolism, raised the question
of whether diﬀerent muscles or muscles with diﬀerent ﬁber
type distributions may be diﬀerentially sensitive to RA-
associated pathology.
Hindawi
Oxidative Medicine and Cellular Longevity
Volume 2019, Article ID 2484678, 11 pages
https://doi.org/10.1155/2019/2484678
Given both the signiﬁcant implication of inﬂammation in
RA and the interlinked nature of inﬂammation and oxidative
stress, attention should also be extended to redox status, in
order to form a more holistic picture of pathological
maladaptations that could potentially be targeted by inter-
vention. In an elegant study on the slow-twitch soleusmuscle
from rats subjected to collagen-induced arthritis (CIA),
peroxynitrite-induced oxidative damage to myoﬁbrillar pro-
teins was implicated in measured deﬁcits of muscle force
production, such as shorter maximal contraction velocity
and slower twitch contraction and relaxation [7]. The same
group subsequently illustrated similar deﬁcits in force pro-
duction—also ascribed to reactive nitrogen species—in the
fast-twitch extensor digitorum longus (EDL) muscle [8].
These studies sketch a fairly ﬁber-type independent picture
of muscle pathology in this model. However, these observa-
tions were made at a relatively advanced time point (≈day
45, with last booster shot on day 28) and do not allow for
direct interpretations on speciﬁc mechanisms at play dur-
ing the earlier, disease development phase. Furthermore,
the degree to which diﬀerent muscle types are compro-
mised in CIA has not been comprehensively and compar-
atively assessed.
The aim of the current study was therefore to assess mus-
cle morphology and selected aspects of muscle pathology and
redox changes in four diﬀerent hindlimb muscles in rats with
collagen-induced arthritis. A somewhat milder model (day
35, with last booster shot on day 8) was employed in order
to elucidate the extent to which free radical involvement
and endogenous antioxidant mechanisms may contribute to
early pathology in diﬀerent muscles.
2. Materials and Methods
2.1. Ethics Statement and Animal Handling. The Stellenbosch
University Animal Research Ethics Committee ethically
cleared this study (Protocol number: SU-ACUD17-00034).
Twenty (20) female Sprague-Dawley rats weighing 180–
200 g were procured from the Stellenbosch University small
laboratory animal breeding facility. They were housed in
groups of 5 rats per cage in a temperature- and humidity-
controlled room (23 ± 1°C, 40–60% humidity) with a set
12 h light-dark cycle and fed standard commercially available
rat chow and tap water ad libitum. After acclimatization to
the new environment for about 7 days, rats were randomly
divided into two groups of 10 rats each—normal control
(NC) and collagen-induced rheumatoid arthritis (RA). All
experimental animals received humane care according to
the principles outlined in the National Research Foundation
Guide for the Care and Use of Laboratory Animals.
2.2. Collagen-Induced Rheumatoid Arthritis Model
2.2.1. Chemicals. Bovine collagen type II, incomplete
Freund’s adjuvant, and rat anti-collagen IgG ELISA kit were
purchased from Chondrex Inc., WA, USA. Isoﬂurane (Iso-
for) was purchased from Safeline Pharmaceuticals, Johannes-
burg, South Africa. All other chemicals and reagents used in
this study were of analytical grade and purchased from
Sigma-Aldrich (MO, USA) or Merck (Darmstadt, Germany)
unless otherwise stated.
2.2.2. Experimental Design. The well-established rat collagen-
induced arthritis (CIA) method [9, 10] was used to induce
arthritis in the RA group. Brieﬂy, bovine heterologous type
II collagen was ﬁrst dissolved in 0.01N glacial acetic acid
(2mg/ml) before an emulsion was prepared using an equal
volume of incomplete Freund’s adjuvant. This emulsion
was slowly injected intradermally twice just above the tail
region of each rat under isoﬂurane anesthesia, 7 days apart.
The time of onset of swelling in rat paws was recorded. The
progression of clinical symptoms was monitored daily and
scored as follows: 0 =no swelling; 1 =erythema and digits
swollen; 2 =erythema, digits, and pad swollen; and 3 =ery-
thema, also digits, pad,joints and entire leg swollen. The total
score for each rat was given as the addition of all aﬀected
paws, so the highest attainable score was 10 for each rat, as
previously described [11].
After the 5-week experimental period, all rats were killed
by guillotine decapitation and the trunk blood was immedi-
ately collected into tubes via a heparinized funnel. The
plasma was subsequently separated after centrifugation at
2,000g for 10 minutes using a Spectrafuge 24D centrifuge
(Labnet International Inc., NJ, USA). The EDL, gastrocne-
mius, and soleus and vastus lateralis muscles from the hind-
quarters of each rat were removed carefully, weighed, snap-
frozen in liquid nitrogen, and then stored at -80°C until sub-
sequent analysis.
2.2.3. Validation of Model via Plasma Anti-Collagen IgG
Titer. The successful induction of arthritis in rats was con-
ﬁrmed by the production of antibodies to type II collagen
using the rat anti-collagen IgG ELISA kit (Chondrex Inc.,
WA, USA) and following the manufacturer’s protocol.
2.3. Muscle Histology. Frozen tissues (EDL, gastrocnemius,
and vastus lateralis) were sectioned in 10μm cross sections
with a cryostat (Leica CM1860 UV, Leica Biosystems
Nussloch GmbH, Germany) at -25°C and stored at -20°C.
To ensure consistency between samples, a predetermined
section was cut oﬀ the proximal end of each sample (diﬀered
between muscle types) before sectioning occurred. This is
particularly important in the vastus lateralis as diﬀerent ﬁber
type proportions exist in the diﬀerent areas (superﬁcial vs.
deep and proximal vs. distal) [12]. Sections were allowed to
thaw at room temperature for 20 minutes before staining.
2.3.1. Hematoxylin and Eosin Staining. H&E staining was
used to view the overall muscle structure. Hematoxylin binds
to and stains all DNA/RNA structures blue. Eosin counter-
stains all proteins of the tissue pink. Slides were submerged
in the following order for one minute each, excluding eosin
which was stained for 30 seconds: dH2O, two changes of
Mayer’s hematoxylin, warm tap water, Scott’s tap water,
dH2O, eosin, H2O, 95% ethanol, 100% ethanol, and ﬁnally
clearance in xylene. Once stained, the slides were mounted
with mounting media (DPX, 06522, Sigma-Aldrich, USA)
and covered with a cover slip for viewing.
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2.3.2. Picrosirius Red Staining. Sirius red is a polyazo dye
which is speciﬁcally used for staining collagen. The stain dyes
collagen bright red, leaving muscle ﬁbers, cytoplasm, and red
blood cells a lighter yellow/red color. Picrosirius red diﬀers
from sirius red staining with the addition of picric acid which
prevents the indiscriminate staining of noncollagenous struc-
tures by sirius red.
Sections were ﬁxed in neutral buﬀered formalin for 30
minutes. Slides were rinsed in dH2O and stained with Wei-
gert’s hematoxylin for 8 minutes. Sections were washed in 3
changes of water followed by staining with picrosirius solu-
tion for one hour. Picrosirius solution was made up of 0.5 g
sirius red F3B (CI35780, Sigma-Aldrich, USA) in 500ml sat-
urated aqueous picric acid (197378, Sigma-Aldrich, USA).
Sections were washed in 0.5% acetic acid (A6283, Sigma-
Aldrich, USA) in dH2O twice for 5 minutes each. Sections
were then dehydrated in changes of ethanol (70%, 95%, and
100%) and then cleared in xylene (296325, Sigma-Aldrich,
USA), and cover slips were mounted with mounting media
(DPX, 06522, Sigma-Aldrich, USA).
2.3.3. Image Acquisition. All histological slides were viewed
using bright-ﬁeldmicroscopy (Nikon Eclipse E400),mounted
with a camera (Nikon DS-Fi2), and processed through a dig-
ital sight processor (DS-U3, Nikon, Japan). Image processing
was done on Nikon Instruments Software (NIS-Elements
v4.10) on a desktop computer (Dell, USA) running Windows
7 (Microsoft, USA). Images were taken at 100x and 200xmag-
niﬁcations (magniﬁcation was calculated from ocular lens
(10x) multiplied by objective lens (10x/20x)).
2.3.4. Image Analysis. The cross-sectional area of the ﬁbers
was measured using H&E sections and ImageJ software (ver-
sion 1.49, Wayne Rasband). 50 ﬁbers per sample were mea-
sured. In order to assess ﬁbrosis, picrosirius red images
were analyzed using ImageJ software (version 1.49, Wayne
Rasband) with the color deconvolution plug-in as developed
by Landini (version 1.5). The picrosirius stains were proc-
essed using the ImageJ RGB option. Brieﬂy, the plug-in
unmixes the RGB image into three 8-bit images with a color
lookup table that corresponds to the respective vector colors.
The analysis measurements were set to measure “area,” “area
fraction,” “limit to threshold,” and “display label.” The
threshold of each of the three images was adjusted allowing
the measurement of (1) the background, (2) the connective
tissue, and (3) total tissue. Percentage of ﬁbrosis in the tissue
(×100 magniﬁcation) was calculated as follows: (1) back-
ground was subtracted from both the connective tissue and
total tissue and (2) the following formula was used:
percentage of fibrosis = connective tissue/ connective tissue
+ total tissue ∗ 100.
2.4. Sample Analysis for Redox Status
2.4.1. Oxidative Stress. Frozen vastus lateralis, soleus, EDL,
and gastrocnemius tissues were thawed on ice and homoge-
nized 100mg/ml in 10mM phosphate-buﬀered saline (PBS,
pH7.2) and centrifuged at 10,000g for 15min at 4°C to
obtain the supernatants used for the analyses. The presence
of reactive oxygen species (ROS) in tissue homogenates
was evaluated by the ROS-dependent oxidation of the non-
ﬂuorescent 2′,7′-dichloroﬂuorescein- (DCF-) DiOxyQ probe
to the highly ﬂuorescent DCF using the OxiSelect™ ROS
assay kit (Cell Biolabs Inc., CA, USA) and following the
manufacturer procedure. The ferric ion reducing antioxidant
power (FRAP) value in all muscle homogenates was deter-
mined by measuring the reduction of ferric tripyridyltriazine
(Fe3+-TPTZ) complex to the ferrous (Fe2+) form by antioxi-
dants as detailed earlier by Benzie and Strain [13]. This is
monitored by the change in absorption at 593 nm in a SPEC-
TROstar Nano® absorbance plate reader (BMG Labtech,
Ortenberg, Germany). Lipid peroxidation in muscle homog-
enates was evaluated by the formation of the stable pro-
duct—malondialdehyde (MDA)—in a reaction medium
containing thiobarbituric acid (TBA). We used the method
described by Varshney and Kale [14] but with slight modiﬁ-
cations: brieﬂy, the MDA formed in tissues highly reacts
with TBA under acidic conditions to form a complex that
is better puriﬁed by the addition of butanol and saturated
sodium chloride and absorbs maximally at 532nm using a
SPECTROstar Nano® absorbance plate reader (BMG
Labtech, Ortenberg, Germany).
2.5. Statistical Analysis. Eﬀects were compared for statistical
signiﬁcance using Student’s t-tests or one- or two-way anal-
ysis of variance (ANOVA) as appropriate, with Bonferroni
post hoc tests where applicable. Data are presented as means
and standard deviations, unless otherwise indicated. Statisti-
cal signiﬁcance was set at P < 0 05.
3. Results
Successful induction of relatively mild rheumatoid arthritis
was conﬁrmed by clinical observations (Figure 1). Onset of
joint swelling was typically within 11-18 days after the ini-
tial exposure to collagen. In addition, signiﬁcantly elevated
levels of anti-collagen antibody titer were measured in RA
animals (0 02 ± 0 007 g/ml plasma; P < 0 0001) when
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Figure 1: Weekly scores indicative of clinical symptoms of arthritis
development in a collagen-induced rheumatoid arthritis model in
female Sprague-Dawley rats (n = 10 per group). Statistical analysis:
one-way ANOVA with repeated measures and Bonferroni post
hoc test. ∗∗∗, p < 0 0001 signiﬁcantly diﬀerent from controls.
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compared to non-RA controls, in which antibody levels
were not detectable.
RA animals exhibited signiﬁcant decreases in skeletal
muscle mass in the EDL, gastrocnemius, and soleus muscles,
but that of vastus lateralis signiﬁcantly increased (Figure 2).
RA animals exhibited clear signs of myoﬁber atrophy
(Figures 3 and 4), inﬂammation (Figure 5), and ﬁbrosis
(Figure 6) when compared to control animals. In line with
the signiﬁcantly decreased muscle mass, the gastrocnemius,
soleus, and EDL muscles exhibited generalized cachexia
which was characterized by a ≈60% reduction in myoﬁber
cross-sectional area across all cells (Figures 3(a)–3(f), 3(j)–
3(l)). In these muscles, a signiﬁcant number of ﬁbers under-
going degradation were visible, as well as edema and inﬂam-
matory cell inﬁltrate. In contrast, as suggested by the lack of
muscle mass loss, vastus lateralis myoﬁbers seemed least
aﬀected by RA, with cross-sectional area of ﬁbers decreasing
by only ≈20% (Figures 3(g)–3(i)). In this muscle group, the
pattern of cachexia was also more varied: while some ﬁbers
of smaller cross-sectional area are visible, normal-sized ﬁbers
are still abundant. No evidence of myoﬁber degradation was
visible in vastus lateralis sections analyzed.
An analysis of ﬁber size distribution (Figure 4) conﬁrms
these observational data. The gastrocnemius, soleus, and
EDL muscles exhibited a shift to the left for ﬁber size, with
very high frequency of small ﬁber size. The vastus lateralis
muscle did not show a clear shift to the left, although fre-
quency of smaller ﬁbers did appear somewhat higher.
Although inﬂammation was not a speciﬁc focus of this paper
and speciﬁc inﬂammatory markers were not assessed, the RA
animals clearly exhibited moderately severe levels of inﬂam-
mation in the soleus, gastrocnemius, and EDLmuscles, where
inﬂammation was visible in the perivascular areas as well as
in between individual myoﬁbers (Figures 5(a) and 5(b)). In
addition, intraﬁber necrosis was visible in several cells
(Figure 5(c)). These features were not clearly visible in the
vastus muscle.
In terms of ﬁbrosis (collagen accumulation), the vastus
lateralis and EDL muscles exhibited a signiﬁcant 50%
increase when compared to their respective controls. A sim-
ilar result was obtained in the soleus but did not reach statis-
tical signiﬁcance. In contrast, the gastrocnemius muscle was
most severely compromised, exhibiting a striking 200%
increase in collagen accumulation (Figure 6).
In terms of redox status, total reactive oxygen species
(ROS) levels seemed to correspond to muscle pathology in
RA, as ROS was signiﬁcantly increased in the gastrocnemius,
EDL, and soleus, but not vastus, muscles of RA animals when
compared to controls (Figure 7(a)). TBARS was assessed as a
measure of oxidative stress-associated membrane damage
through lipid peroxidation (Figure 7(b)). When considering
controls only, the lowest ROS production seen in the gastroc-
nemius muscle corresponded to lowest levels of TBARS in
this muscle, with highest TBARS levels measured in the
EDL and soleus muscles. This relatively poorer picture in
terms of oxidative damage in the control EDL and soleus
muscles was not matched by a relative increase in antioxidant
capacity (FRAP) (Figure 7(c)), suggesting that under normal
conditions, these muscles are relatively more compromised
than the gastrocnemiusmuscle in this context. In RA animals,
lipid peroxidation (TBARS) levels were only signiﬁcantly ele-
vated from control levels in the gastrocnemius muscle
(Figure 7(b)). Similarly, antioxidant capacity (FRAP) was
similar and unchanged by RA in most muscles, with the
exception of the gastrocnemiusmuscle, in which it was signif-
icantly increased in response to RA (Figure 7(c)).
4. Discussion
The current study expands on available literature by present-
ing a comparative assessment of diﬀerent hindlimb skeletal
muscles aﬀected by CIA in a rat model. A speciﬁc novel com-
ponent is the comparison of four diﬀerent muscles with
diﬀerent ﬁber type distributions, including the vastus latera-
lis, in which human studies are typically conducted. Impor-
tantly, a recent study conducted in humans reported that
intramuscular (vastus lateralis) levels of inﬂammatory
parameters, such as the inﬂammatory cytokines, did not cor-
respond to the proﬁle in circulation [6], which highlights the
importance of tissue-speciﬁc investigation and the relevance
of the study reported here.
Data presented here clearly illustrates the debilitating
nature of CIA and validates this model as an accurate simu-
lation of muscle pathology in rheumatoid arthritis. Current
data for the ﬁrst time provides a comparative histological
assessment of four muscles, three of which (the gastrocne-
mius, soleus, and EDL muscles) are directly associated with
the primarily aﬀected joint (ankle), while the other (vastus
lateralis) is more proximal. The fact that all four muscle
groups exhibited signs of cachexia, albeit it much less severe
in the vastus lateralis, suggests that inactivity-based atrophy
is not the only contributor to the pathology observed and that
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Figure 2: Muscle mass of diﬀerent rat hindlimb skeletal muscles on day 35 of CIA (n = 10 per group). Bars indicate mean mass of muscle (left
and right muscle weights were averaged for each animal) and error bars are standard deviations. Statistical analysis: Student’s t-test.
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circulating mediators likely impact signiﬁcantly on all muscle
groups, irrespective of their anatomical position. This gener-
alized muscle deterioration is in line with the human clinical
proﬁle of RA [15] and further validates our model.
The smaller ﬁber size observed in all muscle groups
assessed in the current study could theoretically be the result
of a shift in ﬁber type favoring type I oxidative ﬁber pheno-
type, which is generally smaller than glycolytic myoﬁbers.
This is however unlikely, since skeletal muscle wasting in
COPD and other chronic diseases characterized by chronic
inﬂammation has been reported to be associated with a shift
in phenotype towards type II glycolytic ﬁbers [16, 17]—
which are incidentally also most susceptible to cachexia in
general [18, 19] and speciﬁcally also to arthritis-associated
cachexia [20]. This led to the hypothesis that a loss of muscle
oxidative phenotype may result in increased susceptibility to
inﬂammation [16] and oxidative stress-induced cachexia.
The inclusion of more muscle groups in the current study
provided the opportunity to gain novel insights and indeed
suggested that ﬁber type and metabolic preference alone are
not major determinants of the sensitivity of myoﬁbers to
rheumatoid cachexia. In the current study, the extent of mus-
cle ﬁber atrophy was similar for the soleus, gastrocnemius,
and EDL muscles—muscles which share an anatomical site
in the lower hindlimb but diﬀer in terms of ﬁber type distri-
bution and metabolic preference. The lack of more extended
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Figure 3: Representative H&E images and cross-sectional area of the gastrocnemius (a–c), EDL (d–f), and vastus lateralis (g–i) muscles
depicting ultrastructural changes in female rats subjected to CIA (n = 10 per group) (normal control left; CIA right). 200x magniﬁcation.
Scale bar represents 100μm. Statistical analysis: Student’s t-test.
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Figure 4: Continued.
6 Oxidative Medicine and Cellular Longevity
time points in the cross-sectional design of the current study
however did not allow for assessment of change within the
same muscle over time, to determine if muscles with diﬀerent
ﬁber types or metabolic preferences may respond diﬀerently
over time or with disease progression. Thus, causal mecha-
nisms potentially at play should be investigated in a study
with longitudinal design including early, medium, and
long-term disease progression time frames. The extent of
inﬂammation and its eﬀect on muscle deterioration should
also be considered in such a study of longitudinal design.
In the current study, diﬀusely spread inﬂammation was
clearly visible in muscle assessed, but a comprehensive
assessment of inﬂammation was beyond the current scope.
Nevertheless, skeletal muscle ﬁbrosis has previously been
linked to inﬂammatory processes and was quantitatively
assessed. Fibrosis resulting from inﬂammation and associ-
ated oxidative damage in various models speciﬁcally links
ROS production to modulation of transforming growth fac-
tor beta (TGF-β) signaling in the context of mitochondrial
dysfunction [21–24]. This prompted an investigation into
potential diﬀerences in redox status between the diﬀerent
muscles. Indeed, in the current study, even in the absence
of CIA, the vastus lateralis, EDL, and soleusmuscles exhibited
higher levels of TBARS than the gastrocnemiusmuscle, which
also exhibited lower ROS levels than all other muscles
assessed. This is in line with previous reports of diﬀerential
inherent superoxide dismutase activity, glutathione peroxi-
dase activity, and malondialdehyde levels in diﬀerent muscles
(diaphragm, soleus, and gastrocnemius) [25]. When subjected
to CIA, even though ROS increased in the gastrocnemius,
EDL, and soleus, FRAP remained unchanged in the EDL
and soleus, while in contrast, in the gastrocnemius muscle,
FRAP increased signiﬁcantly in response to the increased
ROS of RA. Together, these data suggest that the EDL and
soleus muscles may have relatively less inherent antioxidant
capacity to react to oxidative stressors when compared to
the gastrocnemius muscle, which was able to mount a
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Figure 5: Representative high-resolution H&E stained images
illustrating inﬂammatory cell inﬁltration in (a) perivascular and
(b) interﬁber areas, as well as (c) intraﬁber necrosis. 200x
magniﬁcation. Scale bar represents 100μm.
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signiﬁcant antioxidant response. Despite this, the gastrocne-
miusmuscle exhibited a worse proﬁle in terms of malondial-
dehyde (MDA) production. We propose that the EDL and
soleus muscles may possess antioxidant mechanisms other
than those assessed by the FRAP assay, which could have
upregulated activity in response to CIA and by which mem-
brane integrity may be maintained. These mechanisms
would be independent of ferric iron reduction speciﬁcally,
which is assessed by the FRAP assay reported here. This
interpretation is in line with the report in a model of
high-fat diet-induced oxidative stress in rats, which reported
that increased ROS production (reduced mitochondrial
H2O2 emission, increased palmitate oxidation, and increased
mRNA expression of NADPH complex) in muscle was paral-
leled by an increased ROS buﬀering capacity (increased
mRNA expression of the antioxidant proteins, manganese
superoxide dismutase (MnSOD), glutathione reductase, and
mitochondrial thioredoxin-dependent peroxide reductase 3
and 5) [26]. Another mechanism by which this may poten-
tially be achieved in the current context is that the EDL and
soleus muscles may contain relatively higher concentrations
of vitamin E, which is known to contribute to cell membrane
repair after oxidative damage. In line with this, although the
majority of data was generated in preclinical models and no
comparison between muscles with diﬀerent ﬁber types could
be found, several beneﬁcial eﬀects of vitamin E were recently
reported in the context of age-related sarcopenia. These
included myoblast proliferation and diﬀerentiation, survival,
membrane repair, mitochondrial eﬃciency, and mainte-
nance of muscle mass and contractile capacity [27]. Of
G
as
tr
oc
.
NC RA
0
5
10
15
20
p < 0.0001
Pe
rc
en
ta
ge
 co
lla
ge
n
ED
L
NC RA
0
5
10
15
20
25
p < 0.05
Pe
rc
en
ta
ge
 co
lla
ge
n
V
as
tu
s l
.
NC RA
0
5
10
15
p < 0.05
Pe
rc
en
ta
ge
 co
lla
ge
n
So
le
us
NC RA
0
5
10
15
20
25
Pe
rc
en
ta
ge
 co
lla
ge
n
Figure 6: Representative images and percentage ﬁbrosis of gastrocnemius (a–c), EDL (d–f), and vastus lateralis (g–i) in female rats subjected
to CIA (n = 10 per group) using picrosirius red staining (normal control left; CIA right). 200x magniﬁcation. Scale bar represents 100μm.
Statistical analysis: Student’s t-test.
8 Oxidative Medicine and Cellular Longevity
particular relevance to the current discussion, vitamin E sup-
plementation was shown to prevent upregulation of muscle
ring ﬁnger 1 (MuRF1) and caspase-9 and caspase-12 mRNA
in unloaded rat muscle and to decrease upregulation of mus-
cle calpain, caspase-3, and atrogin-1 (MAFbx) mRNA [28].
This would suggest that in addition to its antioxidant eﬀect,
vitamin E may also modulate atrophy via more direct inhib-
itory action on proteolytic pathways. The review by Chung
and colleagues [27] highlighted the lack of clinically relevant
information currently available on vitamin E content or pro-
tective properties in skeletal muscle, which up to now has
been limited by methodological constraints. This warrants
further investigations in order to elucidate how endogenous
protective mechanisms may be exploited by exogenous
means for therapeutic beneﬁt.
Redox status is a major determinant of muscle patholo-
gy—and speciﬁcally chronic disease-related cachexia. The
current study focused on oxidative stress resulting from reac-
tive oxygen species. However, both oxidative and nitrosative
stresses may also come into play here, as both have been
implicated in cancer cachexia [29]. In addition, in rodents
injected with lipopolysaccharide (LPS) to induce oxidative
stress, inducible nitric oxide synthase (iNOS) was implicated
as a role player in relatively greater resistance to atrophy and
ubiquitin-associated protein degradation in oxidative, but
not glycolytic ﬁbers [17]. This suggests that future studies
should also determine the interaction between these species
but also that antioxidant treatments should be investigated
as preventative modality or adjuvant treatment in RA.
Indeed, astaxanthin—a powerful antioxidant—was reported
to attenuate immobilization-induced increased collagen
deposition via modulation of oxidative stress, most notably
via altered SOD-1 and TGF-β signaling in rats [24].
Similarly, the antioxidant ﬂavone mixture isoﬂavin-β was
reported to attenuate toxin-induced loss of gastrocnemius
muscle mass by preventing the oxidative modiﬁcation of
proteins [30].
Another observation that has remained unnoticed up to
now is the fact that in the rodent model of CIA, the response
in the vastus lateralis muscle was diﬀerent from other mus-
cles assessed here and also diﬀerent from results previously
reported for the EDL and soleus in rodent models of arthritis
[7, 8]. Current data suggest that although the vastus lateralis
myoﬁbers exhibited some signs of deterioration, total muscle
mass actually increased signiﬁcantly. The ﬁber size variation
in this muscle did not display the characteristic left shift asso-
ciated with cachectic atrophy, although the mean cross-
sectional area was somewhat reduced. This suggests that the
vastus may have been recruited as usual for gait despite the
presence of RA-related symptoms. In contrast, the severe
pathology evident in the gastrocnemius and EDL muscle
groups may have resulted not only from systemic eﬀects
Gastroc. EDL Vastus L. Soleus
0.0
0.1
0.2
0.3
0.4
0.5
NC
RA
p < 0.0001 p < 0.05 p < 0.0005
RO
S
(n
m
ol
 D
CF
 p
ro
du
ce
d 
/ g
 ti
ss
ue
)
p < 0.0001
p < 0.0001
p < 0.0001
(a)
NC
RA
Gastroc. EDL Vastus L. Soleus
0
1
2
3
p < 0.005
p < 0.0001
TB
A
RS
(n
m
ol
 M
D
A
 fo
rm
ed
 / 
g 
tis
su
e)
p < 0.0001
p < 0.0001
(b)
Gastroc. EDL Vastus L. Soleus
0.0
0.1
0.2
0.3
0.4
0.5 p < 0.0001
FR
A
P
(휇
m
ol
 / 
g 
tis
su
e)
NC
RA
(c)
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but also due to lesser recruitment for gait and posture. This
result stresses the importance of data interpretation in con-
junction with clinical observations.
In terms of limitations, although not directly assessed, in
our opinion, muscle mass is unlikely to have been inﬂuenced
by energy intake, as animals did not exhibit clear loss of appe-
tite. In terms of disuse as a confounding factor, although RA
animals walked with a limp due to aﬀected joints, they still
moved around readily in their cages. Furthermore, a compar-
ative study between immobilization and CIA-associated
muscle atrophy has reported both proteolytic and regenera-
tive pathways to be upregulated in RA (but not in experimen-
tally immobilized) animals [31]. Thus, disuse is unlikely to
have been a major confounding factor in the current study.
Finally, edema was not quantiﬁed in the current study, but
may aid in the interpretation of, e.g., the increased vastus
lateralis muscle mass despite the presence of other signs of
atrophy. Inclusion of this measure in studies investigating
inﬂammatory mechanisms in the context of RA-associated
muscle deterioration could further elucidate diﬀerences in
the responses of diﬀerent muscles to the challenges of RA.
5. Conclusion
Data presented here highlight the relevance of muscle-
speciﬁc (and not just ﬁber-type-speciﬁc) assessment of redox
proﬁle to determine its role in muscles’ atrophy response to
experimentally induced rheumatoid arthritis. Furthermore,
current data indicating diﬀerential responses by diﬀerent
muscles suggest that in human studies, it would be pru-
dent to investigate muscle response to RA in more than
one muscle. This would provide more insight into whether
loadbearing and non-loadbearing muscles, or muscles at
diﬀerent anatomical proximities from clinically aﬀected
joints, are also diﬀerentially aﬀected in humans in terms
of disease-related cachexia. Similarly, given the inherently
diﬀerent redox proﬁles and seemingly diﬀerent predomi-
nating endogenous antioxidant mechanisms at play in
the diﬀerent muscles as demonstrated in rats here, inter-
ventions aimed at improving redox status should take
into consideration conditions in (and responses of) more
muscles than just the human vastus lateralis, as diﬀerent
muscles may have diﬀerent therapeutic requirements in
this context.
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